According to the report "New Opportunities in the Era of Great Health: Forward Thinking for the Future Life" released by Tianyancha and Baidu Finance at the end of November 2021, 52 medical and health enterprises in China have been listed on the "Global Unicorn Top 500 Companies", ranking second in the world in terms of number. The total valuation of Chinese healthcare companies reached US $217.682 billion, an increase of US$66.167 billion from 2020.

As the public's demand for health increases year by year, people have a deeper understanding about specialist healthcare and cutting-edge medical technology. Aurora Healthcare US Corp (Aurora) which was founded in Boston, USA in 1999, has strong influence at home country and abroad. While introducing cutting-edge technologies, Aurora integrates resources, bases itself on professional fields, and constantly strives for excellence. After years of development, it has become a leader in the domestic medical industry.

On June 6, 2022, Aurora's first breast center in China, Aurora Breast Center in Chengdu (Chengdu ABC), officially signed a contract with Ping An Health (Hainan Branch), a subsidiary of Ping An of China. Chengdu ABC is officially listed in Ping An Health app, becoming their professional product supplier in the field of women's health management. This is the first step in the strategic cooperation between Aurora and Ping An of China. The two sides will also conduct more in-depth cooperation and jointly explore a new health maintenance organization (HMO) model for breast disease.

Aurora has a high reputation as a global R & D and product supplier of dedicated breast MRI. Aurora has made a special contribution to the field of precision and early diagnosis of breast cancer due to sensitivity and accuracy demonstrated by its dedicated breast MRI, which not only greatly improves the early detection rate, but also enables early diagnosis of microscopic breast lesions to prevent breast cancer. Compared with the whole-body MRI, Aurora dedicated breast MRI is also more comfortable for patients and more suitable for Oriental women with dense breast.

In 2016, Aurora officially entered China's healthcare market. In 2019, Aurora came to Sichuan and joined hands with Sichuan Provincial People's Hospital to build Chengdu ABC (HuanHuaXiang Clinic), creating a comprehensive service model for breast cancer "prevention, diagnosis, treatment and rehabilitation", to take good care for Sichuan women's breast health. In 2020, under the leadership of China Women's Development Foundation, the pilot project of two-cancer screening in Sichuan Province was launched in Xindu District. As a supplier of precise diagnostic tools and services for breast cancer, Aurora participated in exploring the "three innovations" of breast cancer screening: Innovation in screening methods, innovation in technical services, and innovation in payment models. To integrate commercial health insurance into payment model is the key exploration point in the series of "three innovations" work.

As one of the leading enterprises of Internet medical and healthcare service, Ping An Health has accumulated 420 million registered users and provided over 1.27 billion consultations. It integrates six characteristic services, including: family doctor, famous doctor consultation, healthy community, health assessment, health habits and health records, to provide users with one-stop health consultation and health management services.

In recent years, Aurore has never stopped to explore the new HMO model of "preventive medicine" and "innovative insurance". By joining hands with Ping An Health, Aurora is looking forward to exploring a win-win cooperation mechanism among enterprises, customers, medical institutions and insurance companies by taking breast disease as the entry point, integrating the advantages of both parties, and combining comprehensive solutions for breast diseases with innovative insurance products to effectively save enterprise's and individual's expenses.

The advantage of Aurora dedicated breast MRI to give a precise diagnosis is a key point of this new model. In the context of the policy dividend of the Healthy China National Strategy, while Aurora successfully cooperates with Ping An Health to practice the HMO model for breast disease, it could become the reference for disease prevention and businesses development in other fields.